| 64Cu-DOTATATE PET in patients with neuroendocrine neoplasms: prospective, head-to-head comparison of imaging at 1 hour and 3 hours after injection M Loft, EA Carlsen, CB Johnbeck, HH Johannesen, T Binderup, A Pfeifer, ... Journal of Nuclear Medicine 62 (1), 73-80, 2021 | 33 | 2021 |
| Preclinical Study on GRPR-Targeted 68Ga-Probes for PET Imaging of Prostate Cancer Y Sun, X Ma, Z Zhang, Z Sun, M Loft, B Ding, C Liu, L Xu, M Yang, Y Jiang, ... Bioconjugate chemistry 27 (8), 1857-1864, 2016 | 32 | 2016 |
| 64Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms EA Carlsen, CB Johnbeck, T Binderup, M Loft, A Pfeifer, J Mortensen, ... Journal of Nuclear Medicine 61 (10), 1491-1497, 2020 | 30 | 2020 |
| Semiautomatic tumor delineation for evaluation of 64Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor … EA Carlsen, CB Johnbeck, M Loft, A Pfeifer, P Oturai, SW Langer, ... Journal of Nuclear Medicine 62 (11), 1564-1570, 2021 | 27 | 2021 |
| Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: implications for uPAR-targeted therapy EA Carlsen, M Loft, A Loft, AK Berthelsen, SW Langer, U Knigge, A Kjaer Journal of Nuclear Medicine 63 (9), 1371-1377, 2022 | 14 | 2022 |
| A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms EA Carlsen, K Lindholm, A Hindsholm, M Gæde, CN Ladefoged, M Loft, ... EJNMMI research 12 (1), 30, 2022 | 14 | 2022 |
| The CPC risk calculator: a new app to predict prostate-specific antigen recurrence during follow-up after radical prostatectomy MA Røder, KD Berg, MD Loft, FB Thomsen, M Ferrari, S Kurbegovic, ... European Urology Focus 4 (3), 360-368, 2018 | 14 | 2018 |
| Multimodality hyperpolarized C-13 MRS/PET/multiparametric MR imaging for detection and image-guided biopsy of prostate cancer: first experience in a canine prostate cancer model SV Bachawal, JM Park, KS Valluru, MD Loft, SA Felt, JG Vilches-Moure, ... Molecular Imaging and Biology 21, 861-870, 2019 | 11 | 2019 |
| A randomized, factorial phase II study to determine the optimal dosing regimen for 68Ga-satoreotide trizoxetan as an imaging agent in patients with gastroenteropancreatic … I Virgolini, S Bahri, A Kjaer, H Grønbæk, P Iversen, EA Carlsen, M Loft, ... Journal of Nuclear Medicine 63 (3), 376-383, 2022 | 8 | 2022 |
| Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR) MD Loft, Y Sun, C Liu, C Christensen, D Huang, A Kjaer, Z Cheng Amino Acids 49 (6), 1089-1100, 2017 | 8 | 2017 |
| First-in-humans PET imaging of tissue factor in patients with primary and metastatic cancers using 18F-labeled active-site inhibited factor VII (18F-ASIS): potential as … M Loft, C Christensen, MM Clausen, EA Carlsen, CP Hansen, N Kroman, ... Journal of Nuclear Medicine 63 (12), 1871-1879, 2022 | 4 | 2022 |
| [68Ga]Ga-NODAGA-E[(cRGDyK)]2 Angiogenesis PET/MR in a Porcine Model of Chronic Myocardial Infarction S Bentsen, A Clemmensen, M Loft, M Flethøj, KP Debes, TP Ludvigsen, ... Diagnostics 11 (10), 1807, 2021 | 4 | 2021 |
| Initial Experience with 64Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET M Loft, CB Johnbeck, EA Carlsen, HH Johannesen, P Oturai, SW Langer, ... Diagnostics 11 (2), 350, 2021 | 4 | 2021 |
| Temporal trends in clinical and pathological characteristics for men undergoing radical prostatectomy between 1995 and 2013 at Rigshospitalet, Copenhagen, Denmark, and Stanford … MD Loft, KD Berg, A Kjaer, P Iversen, M Ferrari, CA Zhang, K Brasso, ... Clinical Genitourinary Cancer 16 (1), e181-e192, 2018 | 4 | 2018 |
| Prospective phase II trial of [68Ga] Ga-NODAGA-E [c (RGDyK)] 2 PET/CT imaging of integrin αvβ3 for prognostication in patients with neuroendocrine neoplasms EA Carlsen, M Loft, A Loft, D Czyzewska, M Andreassen, SW Langer, ... Journal of Nuclear Medicine 64 (2), 252-259, 2023 | 2 | 2023 |
| Development of PET Probes for Molecular Imaging of Tight Junction Membrane Proteins, Claudin-4, in Ovarian Cancer. C Liu, X Li, X Ma, H Zhu, M Loft, H Liu, Z Cheng Journal of Nuclear Medicine 57 (supplement 2), 530-530, 2016 | 2 | 2016 |
| An Investigation of Lesion Detection Accuracy for Artificial Intelligence–Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms M Loft, CN Ladefoged, CB Johnbeck, EA Carlsen, P Oturai, SW Langer, ... Journal of Nuclear Medicine 64 (6), 951-959, 2023 | 1 | 2023 |
| Activity Dose Reduction in 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability M Loft, EA Carlsen, CB Johnbeck, CV Jensen, FL Andersen, SW Langer, ... Molecular Imaging and Biology 24 (4), 600-611, 2022 | 1 | 2022 |
| Editorial for “Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1‐13C] Pyruvate: Metabolism Differs Between Tumors … A Clemmensen, M Loft, A Kjaer, TL Andersen Journal of Magnetic Resonance Imaging 57 (6), 1876-1877, 2023 | | 2023 |
| Editorial for "Application of 3D Multi-Echo Balanced Steady State Free Precession and Hyperpolarized [1-13 C] Pyruvate to Quantify Prostate Cancer Metabolism". A Clemmensen, M Loft, A Kjaer, TL Andersen Journal of Magnetic Resonance Imaging: JMRI, 2022 | | 2022 |
